REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Pharmagal, spol. s.r.o. (Slovakia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Pharmagal, spol. s.r.o. Profile Updated: April 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Pharmagal, spol. s.r.o. is an enterprise in Slovakia, with the main office in Nitra. The company operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on May 17, 1994. 25 - 49 (2023) employees currently work for Pharmagal, spol. s.r.o.. The latest financial highlights indicate a net sales revenue increase of 11.14% in 2023. Its’ total assets recorded a growth of 12.19%. In 2023, Pharmagal, spol. s.r.o.’s net profit margin increased by 9.11%.

Headquarters
Murgasova 5
Nitra; Nitriansky; Postal Code: 94901

Contact Details: Purchase the Pharmagal, spol. s.r.o. report to view the information.

Basic Information
Total Employees:
Purchase the Pharmagal, spol. s.r.o. report to view the information.
Outstanding Shares:
Purchase the Pharmagal, spol. s.r.o. report to view the information.
Registered Capital:
Purchase the Pharmagal, spol. s.r.o. report to view the information.
Incorporation Date:
May 17, 1994
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Pharmagal, spol. s.r.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
11.14%▲
Total operating revenue
26.28%▲
Operating profit (EBIT)
129.78%▲
EBITDA
67.75%▲
Net Profit (Loss) for the Period
162.97%▲
Total assets
12.19%▲
Total equity
10.65%▲
Operating Profit Margin (ROS)
9.69%▲
Net Profit Margin
9.11%▲
Return on Equity (ROE)
5.58%▲
Debt to Equity Ratio
0.02%▲
Quick Ratio
0.35%▲
Cash Ratio
0.85%▲

Similar companies

Johnson & Johnson, s.r.o.
 
HBM Pharma s.r.o.
Unimed Pharma, spol. s r.o.
 
Pharmagal - BIO, spol. s r.o.
Panacea, s.r.o.
 
Farmacia Martin a.s.
Medipharm a.s.
 
G.V.Pharma, a.s.
Institute Europharm, s.r.o.
 
Vitalos s. r. o.

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo